Tag Archives: Increasing

Study Shows that Adolescent ADHD Prescription Drug Abuse is Increasing

July 08, 2012     No comments

Newton, MA (PRWEB) September 22, 2009

A new study published in the journal Pediatrics has revealed a sharp increase in the number of calls to poison control centers regarding teen abuse of prescription medication for Attention Deficit/Hyperactivity Disorder (ADHD). Researchers at Cincinnati Children’s Hospital Medical Center analyzed data from the American Association of Poison Control Center’s National Poison Data System from 1998-2005, and discovered a 76% increase in the number of calls related to the abuse of prescription ADHD medication by adolescents.

To assist families of children with ADHD who may be concerned about this trend, Inflexxion, a behavioral health research company in Newton, MA., has published a free parent toolkit. The online toolkit, designed for families of elementary, middle-school, and high-school students with ADHD, contains practical tools to help parents manage the risks of ADHD medications. Examples include a Medication Contract for parents to use with their children, a Medication Log for tracking the use of ADHD medications, and Sample Letters for communicating with health care providers and teachers about a child’s condition and treatment.

“With the increase in the number of teens misusing or abusing prescription ADHD medications, there is an even greater need for parents, physicians, and teachers to be on the ‘same page’ and to closely monitor adolescents who are being treated for ADHD,” remarks Mary Robertson, RN, co-founder of the Lexington, Kentucky Bluegrass Chapter of Children and Adults with Attention Deficit/Hyperactivity Disorder (CHADD) and a former National President of CHADD. “Inflexxion’s ADHD Toolkit can help families get organized whenever a change in dosage is required or when a new medication is started. As a new school year begins, it is important for parents to communicate any changes in treatment and performance with their child’s teachers and doctors; the toolkit is an excellent resource for tracking.”

The toolkit was created by Inflexxion researchers with guidance from the nationally recognized experts on the Advisory Board for Inflexxion’s InsideADHD.org website. Developed to serve as a comprehensive resource, the website has articles, lessons, and tools to assist with the day-to-day challenges of life with ADHD. Visitors are invited to sign up to receive InsideADHD’s free monthly e-newsletter.

About Inflexxion

Founded in 1989, Inflexxion leverages technology to improve public health. We create clinically validated tools and programs for critical areas of health care, including prevention and wellness education, addiction and pain treatment, and pharmaceutical risk management. These innovative solutions help reduce health-related risks, enhance clinical outcomes, and positively impact the quality of care.

###







More Attention Deficit Hyperactivity Disorder Press Releases

Read More

LegalView Informs Readers of Fake Documents for Asbestos Removal Workers Increasing Risks of Mesothelioma Among Americans

May 29, 2012     No comments

Denver, CO (PRWEB) November 13, 2008

LegalView, the number one resource for everything and anything available on the Web, recently alerted mesothelioma blog readers to a disturbing report from the U.S. Environmental Protection Agency (EPA), which has found thousands of asbestos removal workers to have falsified documents in order to gain employment and thus cause a potential increased risk of asbestos exposure among American citizens, according to an article from the Times-Herald on Nov. 1. The documentation scandal, uncovered by Environmental Protection Division (EPD) worker Don McCarty, found that individuals were allegedly using bogus certifications, false social security numbers and certification from individuals no longer alive in order to have employment, the Times-Herald reports.

It is illegal to work in asbestos removal without authentic certification, as asbestos must be handled carefully in order to avoid exposure of individuals, according to the U.S. Environmental Protection Agency’s office. Because asbestos exposure can cause the development of a deadly form of lung cancer known as mesothelioma, it is important for individuals who feel they have been wrongfully exposed to asbestos fibers to contact a mesothelioma law firm. Contacting such a law firm can offer an array of mesothelioma lawyers and mesothelioma attorneys to choose from in developing a potential mesothelioma lawsuit in which a victim may be able to derive monetary compensation as a potential award for their deadly condition and expensive medical bills.

According to dozens of news reports printed in not only the Times-Herald, but an array of newspapers across the country, many buildings across the United States still contain asbestos, and individuals who have obtained illegal or fake documentation for asbestos removal are putting thousands if not millions of Americans at risk for developing mesothelioma cancer with improper asbestos removal. Asbestos was heavily used during the beginning and middle of the 20th century as a form of inexpensive and fire-retardant insulation in millions of homes, apartment buildings, hospitals, schools, universities and offices. The use of asbestos was later halted after it was linked to the development of mesothelioma cancer. The cancer, unfortunately, remains dormant for years within a victim who is unaware of the cancerous condition forming inside of their body until it is too late. There is currently no cure for mesothelioma cancer.

For more information on this, visit LegalView’s mesothelioma information portal. Individuals can also learn about other legal topics affecting them including dealing with a traumatic brain injury (TBI), a truck accident or how to cope with Avandia side effects.

According to the Brain Injury Association of America (BIAA) nearly 1.4 Americans sustain a brain injury each year and approximately 50,000 of these individuals die while 235,000 are hospitalized and 1.1 million are treated and released. There are a range of severe consequences resulting from being a victim of TBI including social/mental impairment, loss of sensory abilities, lack of motor skills, etc. It is important that individuals who have been injured in a TBI incident contact an experienced TBI attorney who can provide a free legal consultation as to the development of a potential TBI lawsuit.

Truck accidents are the most costly and, unfortunately, linked to the most fatalities among all vehicular accidents. Because a truck accident can affect more than just a victim, it is important that legal counsel be sought to protect a truck accident victim from costly medical bills associated with this type of accident.

LegalView also offers a wide-range of pharmaceutical topics such as the type 2 diabetes drug, Avandia, which has been allegedly linked to the development of heart disease/heart failure and bone fractures/breaks as well as early-onset osteoporosis, according to reports issued by the U.S. Food and Drug Administration on their advisory section of their Web site. Patients who have taken Avandia for their type 2 diabetes should consider speaking with their medical professional about the potential Avandia side effects and can learn more about this and other controversial pharmaceuticals at http://www.LegalView.com/.

About LegalView:

LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation’s most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com’s superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at http://www.LegalView.com.

###







Read More

Increasing Investment in Stem Cell Technology and Promising Research Outcomes Drives the Stem Cell Research Market, According to New Report by Global Industry Analysts

May 12, 2012     No comments

San Jose, California (PRWEB) May 10, 2012

Follow us on LinkedIn ? Stem cell research is a promising area of biotechnology, which holds tremendous potential in rendering a new approach to the treatment of various degenerative diseases. The area deals with employing regenerative stem cells for the replenishment of damaged cells of a particular organ or tissue with new cells. These repair blocks have created a new specialty in the area of medicine called the regenerative medicine. Stem cells hold potential to treat conditions such as Alzheimer?s disease, Parkinson?s disease, stroke, spinal cord injury, heart disease, diabetes, burns, rheumatoid arthritis and osteoarthritis. In addition to its therapeutic applications, stem cells are also finding use in drug discovery, promising new avenues in the area of drug development. Growth in the research space is attributed to the acceptance of stem cell technology by patients for treating chronic diseases. Moreover advancement in stem cell research can help reduce the escalating healthcare costs associated with conventional methods of treatment.

Stem cell technology is still in a nascent stage. The market still lacks substantial data that could establish its long-term efficacy as well as safety. Certain issues pertaining to its administration have also raised concerns. The regulatory and ethical barriers across the world, particularly in Western countries, are the major challenges ahead of stem cells research. The barriers are particularly more in embryonic stem cell research. On the other hand, countries such as India, with comparatively less opposition, are better positioned to conduct stem cell research. Lack of proper funding is also a matter of concern for stem cell research. Countries, such as Thailand, Taiwan, Malaysia, Singapore, China, and India, are engaged in commercial, clinical, and scientific advancements in stem cell research without proper funding.

Over the past few years, the stem cells market has witnessed several breakthroughs that bodes tremendous potential in reshaping the area of medicine. Potential therapeutic applications of stem cells cut across several debilitating and deadly disease areas, including cancer and AIDS. Stem cell research is entering new avenues of medicine, and promises to provide a solution to combat diseases that were hitherto believed to be incurable. There is a growing demand for such therapies, which in turn provokes continued investments in the area, and foretell a remarkable growth in the industry in the coming years. Presently, the field is focused upon the treatment of certain oncological ailments, which include non-Hodgkin’s lymphoma, multiple myeloma, and leukaemia. Additionally, non-cancerous diseases, including lupus, immunodeficiency, and aplastic anaemia, are also being investigated for treatment using stem cell technology.

Mesenchymal stem cells and hematopoietic stem cells, extracted from adult bone marrow, are the leading types of adult stem cells currently in demand in the area of medicine. Of these types, hematopoietic stem cells hold major share in disease management. The dominance of hematopoietic stem cells is in part due to the difficulty associated with the isolation of mesenchymal from the bone marrow owing to availability of cells in lower levels. The greatest strength of adult stem cells is the presence of genomic stability of a very high degree. Additionally, stem cell therapy does not necessitate pre-treatment or genetic modification that is required when dealing with embryonic stem cells.

The US represents the largest regional market worldwide, as stated by the new market research report on Stem Cell Research. Despite the 9-year ban, which ended in 2009, over federal funding for research in embryonic stem cells, North America is presently dominating the stem cell market. Key factors that have kept North American market on the top of the charts include advanced stem cell research infrastructure and facilities, and federal support for the research. Asia is emerging as the fastest growing regional market for stem cell research worldwide with countries such as Japan, China, Singapore, Korea, and Australia evolving as major hubs for stem cell research.

Major players profiled in the report include Advanced Cell Technology Inc., Athersys Inc., Cytori Therapeutics Inc., Genzyme Corporation, Geron Corporation, International Stem Cell Corporation, Mesoblast Ltd., Osiris Therapeutics Inc., StemCells Inc., ThermoGenesis Corp., among others.

The research report titled ?Stem Cell Research: A Global Strategic Business Report? announced by Global Industry Analysts, Inc., provides comprehensive market overview, trends & issues, regulatory overview, overview on therapies under development, recent industry activity and profiles of market players worldwide. The report analyzes global adult stem cell research market in terms of annual investments in value for the years 2008 through 2017, for major geographic markets, including the US, Europe and Rest of World.

For more details about this comprehensive market research report, please visit ?

http://www.strategyr.com/Stem_Cell_Research_Market_Report.asp

About Global Industry Analysts, Inc.

Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world’s largest and reputed market research firms.

Follow us on LinkedIn

Global Industry Analysts, Inc.

Telephone: 408-528-9966

Fax: 408-528-9977

Email: press(at)StrategyR(dot)com

Web Site: http://www.StrategyR.com/

###







Read More

Disabled Veterans National Foundation Applauds Department of Veterans Affairs for Responding to Increasing Needs of Veterans for Mental Health Services

May 01, 2012     No comments

Washington, DC (PRWEB) April 20, 2012

The move by the VA is in response to the growing number of men and women soldiers returning from war needing help for emotional and psychological disorders.

?The invisible wounds of war ? such as post traumatic stress disorder, brain injuries and depression ? are debilitating and as deserving of immediate intervention and treatment as physical injuries,? said Raegen Rivers, Chief Administrative Officer of the DVNF. ?Our collective goal is to bring hope to our heroes, and our country must have the resources in place to immediately intervene and offer help whenever a veteran comes home in need of mental health services.?

The VA announced April 19th that it would add 1,600 clinicians, including psychiatrists, psychologists, nurses, social workers and counselors, and about 300 support staff, in order to deal with a shortage that has become apparent as more veterans return home from the wars in Iraq and Afghanistan. The department?s current mental health staff is about 20,590.

The move is in response to a VA review that revealed shortages in mental health staff nationwide, leading veterans in some areas to wait longer than they should for treatment, according to VA Under Secretary for Health Dr. Robert Petzel. Since 2007, the VA has experienced a 35 percent increase in the number of veterans receiving mental health services. In recent years, suicide rates have risen and surveys have shown that mental health providers cannot schedule a new patient for an appointment within the VA-mandated two weeks. Seventy percent of providers reported that they lack sufficient space and staff to properly treat new and existing patients.

Recruitment for the new positions will begin immediately, with the VA drawing from the military, the private sector and from schools.

About Disabled Veterans National Foundation: DVNF exists to change the lives of men and women who came home wounded or sick after defending our safety and freedom. A non-profit 501(c)(3), DVNF was founded in the fall of 2007 by six women veterans to expand their scope of work within the veteran’s community. For more information, visit http://www.dvnf.org.







Read More

Growing Incidence Rates, Coupled with Increasing Aging Population to Propel Global Anxiety Disorders Market, According to a New Report by Global Industry Analysts, Inc.

April 30, 2012     No comments

San Jose, California (PRWEB) April 27, 2012

Follow us on LinkedIn ? Anxiety disorder is the most commonly occurring mental health condition, affecting individuals of all age groups. The disorder involves unwarranted amount of fear, anxiety, nervousness, dread or worry that renders an affected person tense and distracted. In the recent years, the number of people suffering from anxiety disorders increased considerably owing to the global financial crisis that resulted in rising unemployment rates and increasing stress levels. Ever-increasing aging global population is also one of the factors responsible for the rapid increase in sales of central nervous system drugs. Against this backdrop, there exists an ever-increasing need for developing medications that offer a faster onset of action as compared to the presently available drugs. Subsequently, the anxiety disorders market is expected to witness a transformation, with anti-psychotic drugs expected to change the future landscape of the anxiety disorder drugs market. Seroquel XR is expected to leverage first to market status, subsequent to its approval for use in generalized anxiety disorder. Manufacturers of anti-depressants are expected to enhance their products’ target patient potential, considering the higher co-morbidity between depression and anxiety. However, pharmaceutical companies in the anxiety disorder drugs market are expected to be challenged by the need of maintaining and growing the market share due to the patent expiries of the three major drug brands, including Cymbalta, Lexapro and the extended release version of Effexor, during the period 2011-2013, thereby leading to strong competition among other classes of antidepressant drugs.

Pharmacotherapy, as well as psychotherapeutic approaches, has been established to be effective in treating Generalized Anxiety Disorder (GAD). The combination of these two approaches is expected to curtail limitations of any single approach and result in enhanced improvement in the condition. The combination is also helpful for patients not benefiting from any one of the methods. Several novel therapeutic drugs are currently under development for treating Generalized Anxiety Disorder (GAD). These include agents that act by modifying Neurokinins, Cholecystokinin, ?-aminobutyric acid or GABA, voltage sensitive Ca2+ channels, and serotonin 5-HT1A receptors. Research efforts have strongly moved towards 5-HT1A-Receptor Agonists, following the launch of Buspirone. A promising product in pipeline is Pregabalin that helps in modulating Ca2+ channel flow in hyperexcited neurons.

The US represents the largest regional market for anxiety disorder therapeutics worldwide, as stated by the new market research report on Anxiety Disorders. Anxiety disorders are the most common form of psychological disorder in the US. About 40 million people suffer from an anxiety disorder in the US. About 10 million Americans are believed to visit a psychiatrist for dealing with stress-related issues per annum. Anti-anxiety drugs, antidepressants and tranquilizers account for about 25% of the total prescriptions dispensed in the US per annum. About 27% of the European population suffers from brain disorders, with depression being the most prevalent health problem in several EU-Member States. However, Asia-Pacific is forecast to register the fastest growth during the analysis period, registering a compounded annual growth rate of more than 5.0% during 2009-2017.

Major players profiled in the report include AstraZeneca Plc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Forest Laboratories, Inc., GlaxoSmithKline Plc, H. Lundbeck A/S, Mylan Inc., Neurocrine Biosciences, Inc., Pfizer Inc., Ratiopharm, Sanofi, Valeant Pharmaceuticals, Watson Laboratories, among others.

The research report titled ?Anxiety Disorders: A Global Strategic Business Report? announced by Global Industry Analysts Inc., provides a comprehensive review of the anxiety disorders therapeutics markets, current market trends, key growth drivers, leading drugs in the market, overview of pipeline drugs, recent product approvals/launches, recent industry activity, and profiles of major/niche global as well as regional market participants. The report provides annual sales estimates and projections for anxiety disorders therapeutics market for the years 2009 through 2017 for the following geographic markets – US, Europe, Asia-Pacific, and Rest of World. Also, a six-year (2003-2008) historic analysis is provided for additional perspective.

For more details about this comprehensive market research report, please visit ?

http://www.strategyr.com/Anxiety_Disorders_Market_Report.asp

About Global Industry Analysts, Inc.

Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world’s largest and reputed market research firms.

Follow us on LinkedIn

Global Industry Analysts, Inc.

Telephone: 408-528-9966

Fax: 408-528-9977

Email: press(at)StrategyR(dot)com

Web Site: http://www.StrategyR.com/


###







Read More

How To Grow Taller After Puberty ? Height Increasing Exercises

October 15, 2011     No comments

Do you want to learn height increasing exercises and how to grow taller after puberty? If you still want to grow taller, there are several posture and spine increasing exercises that you can do to increase your height beyond its maximum potential. The first and most important factor would definitely be posture. Having a poor posture can steal a few inches off a person’s height, and good posture can potentially make a short statured person look taller and more powerful.

There is an online program that I followed to increase my height by more than 2 inches. It is an overall exercise and eating program that promotes height growth in the body. Most short people wish to grow taller but generally arrive at the conclusion that height is genetic and that they would have to accept who they are.

]]>

All this has changed with the discovery of spine lengthening and exercises that can be done to promote height growth. The typical results of using this program have been 2 to 3 inches of natural height growth. There are many height increasing exercises that can be used today for growing taller.

The first exercise that you can try is to stretch the spine area near your neck. You can do this by first putting your hand on your chin. As your exhale, bend your neck down and push your chin slightly towards your chest. This should provide a stretching feeling in the back. Repeat this exercise every day and night to stretch and grow the neck area near the spine.

This is an exercise that will stretch your upper back muscles as well as your spine. It also dramatically improves your posture. You do this by rolling your head from the side of your head to the front, the other side and to the back.

Are you looking to gain height and grow taller permanently? Visit the author’s website at http://www.growtallerguidesreview.com where he tells you about the best strategies for growing taller fast!

For a limited time, you can also get a FREE Height E-course where you can learn about the real causes of a lack of height and what you can do to grow again regardless of your age!

Read More

Height Increase After Puberty ? Tips For Increasing Height After Puberty

September 05, 2011     No comments

There is so much controversy about the possibility of increasing height after puberty. Can a fully grown up individual really increase height? This is the question asked by many vertically challenged folks in out societies today, who want to learn more about and its possibilities. This article will try to answer this question and also recommend a great way through which you can use to grow taller even if you have reached puberty.

There is really no scientific evidence yet, to prove that a fully grown up individual can grow taller. This means the notion may or may not be true! However, there are thousands of people in the world who have grown taller after puberty. I for one am one of such individuals. So there is really no need to questions the possibility of increasing height after puberty is reached. You just need to know the correct practices to adopt and follow proven grow taller recommendations.

One of the best ways you can use to add some few more inches to your height even after puberty is reached is by using . Super massing is a very effective height increase after puberty trick which is becoming really popular nowadays. Many people have used this method and have increased 5 or more inches to their height during a 3 months period.

The full details on how the super massing trick works is explained in this great height increase program: InstaHeight Enhancement, which you can download and read what exactly you should do, so as to add up to 5 inches or more to your current height.

Do you want to grow taller using proven and secret techniques which have helped thousands of vertically challenged folks to grow taller by 5 or more inches?

Read More
Powered by WordPress | Designed by: best suv | Thanks to toyota suv, infiniti suv and lexus suv